Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1162
https://www.valueinhealthjournal.com/article/S1098-3015(13)03067-2/fulltext
Title :
Cost-Effectiveness of Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03067-2&doi=10.1016/j.jval.2013.08.1162
First page :
A505
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1012